はじめての方へショーケース価格
  1. 米国企業
  2. AbbVie Inc.

AbbVie Inc.ABBV

時価総額
$2939.8億
PER
60.3倍
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Net earnings-------4,62211,54911,8454,873
Depreciation388383417425425471464666803778752
Amortization of intangible assets5094034197641,1001,3001,6005,8007,7007,7007,900
Deferred income taxes------122-2,325-898-1,931-2,889
Change in fair value of contingent consideration liabilities---228626493,0915,7532,6792,7615,128
Stock-based compensation212241282353365421430753692671747
Payments of contingent consideration liabilities----------870
Acquired IPR&D and milestones-1,1022802804701,0614901,3761,624697778
Stock-based compensation212241282353365421430753692671747
Acquired IPR&D and milestones-1,1022802804701,0614901,3761,624697778
Gain on divestitures------330-68172-
Non-cash litigation reserve adjustments, net of cash payments---------2,243-443
Gain on divestitures------330-68172-
Impairment of intangible assets----3545,0701,030--7704,229
Non-cash litigation reserve adjustments, net of cash payments---------2,243-443
Other, net-34-434-489-429-84-76-43-832-150225
Impairment of intangible assets----3545,0701,030--7704,229
Accounts receivable---71391591749291,3211,455-66
Inventories5620343438-9322623140142686417
Prepaid expenses and other assets-459220-511393118499-97-134197264188
Accounts payable and other liabilities-426-1931,503-1,187425190-1,1211,5141,6281,6053,840
Income tax assets and liabilities, net--------573-1,290542-488
Other, net-34-434-489-429-84-76-43-832-150225
Accounts receivable---71391591749291,3211,455-66
Inventories5620343438-9322623140142686417
Prepaid expenses and other assets-459220-511393118499-97-134197264188
Accounts payable and other liabilities-426-1931,503-1,187425190-1,1211,5141,6281,6053,840
Income tax assets and liabilities, net--------573-1,290542-488
Cash flows from operating activities------13,32417,58822,77724,94322,839
Acquisition of businesses, net of cash acquired40562211,4882,495---38,260525255-
Other acquisitions and investments--9642623087361,1351,4001,4005391,200
Acquisitions of property and equipment491612532479529638552798787695777
Purchases of investment securities9301,1698515,3152,2301,792583611191,43877
Sales and maturities of investment securities2,7051,4778802,3592,7932,1602,6991,525981,53055
Other, net---19-118---167-1,387-366-774-13
Cash flows from investing activities------596-37,557-2,344-623-2,009
Proceeds from issuance of long-term debt--20,66011,627-5,96331,4823,0001,0002,000-
Repayments of long-term debt and finance lease obligations--4,0186,010256,0351,5365,6839,41414,4334,149
Debt issuance costs--18269-4042420--38
Dividends paid2,5552,6613,2943,7174,1075,5806,3667,7169,26110,04310,539
Purchases of treasury stock3206527,5676,0331,41012,0146299789341,4871,972
Proceeds from Stock Options Exercised347225142268254738209244262180
Payments of contingent consideration liabilities----268781633216981,132752
Other, net-66-21730352214358243048
Cash flows from financing activities------14,39618,708-11,501-19,039-24,803-17,222
Effect of exchange rate changes on cash and equivalents----------625
Net change in cash and equivalents--------31,4751,297-5453,613
Interest paid, net of portion capitalized2834195369861,0991,2151,7942,6192,7122,5462,469
Income taxes paid1,3054981,1083,5631,696-1,4471,6743,6482,9884,702
Stock Issued--8,4053,923---23,979---